Original document(12 pages)  中文版
    This invention publishes an antibacterial compound A-45 with a common formula (I), its application in manufacturing antibacterial drugs and its blended composite drugs. This compound, with its pharmacologically permitted ester derivatives, ether derivatives, amino-formyl-N-alkyl derivatives and salts, performs outstanding and broad-spectrum antibacterial activity. It is especially germicidal to leptospiras and some other G- or G+ bacteria and is thus applicable in curing or preventing infection diseases.
Application Number
申请号
200410093534 Application Date
申请日
2004.12.24
Title 名称 Antibacterial compound A-45, and application in preparing antibacterial drug
Publication Number
公开号
1796372 Publication Date
公开日
2006.07.05
Approval Pub. Date Granted Pub. Date
International Classification 分类号 C07D231/22,A61K31/4152,A61P31/04
Applicant(s) Name
申请人
Shanghai Human Gene Group Research Center
Address 地址 201203
Inventor(s) Name 发明人 Zhang Piyan, Yin Shiliang, Qian Zhen
Attorney & Agent 代理人 ding jitie

  
A new marnifi blue mold cell wall surface antigen I, its coding sequence and application thereof
A novel marnifi blue mold cell wall surface antigen II its coding sequence and application thereof
Novel penicillium marneffei ERG1 gene, its coding protein and use
Novel penicillium marnffei PPIase II, its coding sequence and use
Novel penicillium marneffei PPIase II, its coding sequence and use
Antifungal compound and its prepn process and application
Antifungal compound and its prepn process and application
Antibacterial compound A-48, and application in preparing antibacterial drug
Antibacterial compound A-4, and application in preparing antibacterial drug
Antibacterial compound A-4, and application in preparing antibacterial drug
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.